Back

Increase in EPA/AA Ratio Predicts Improvement in Endothelial Function in Purified Eicosapentaenoic Acid-Treated Patients

3 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Lipids Drug therapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Kazuo Fukumoto

Osaka City University Graduate School of Medicine, Osaka (Japan)

14 More presentations in this session

Presentation thumbnail
Doctor C. Caselli (Pisa, IT)
Abstract Slides
Presentation thumbnail
Doctor C. Rodriguez (The Bronx, US)
Abstract
Presentation thumbnail
Professor G. Schwartz (Aurora, US)
Abstract
Presentation thumbnail
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
Professor M. Banach (Lodz, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Lipids

The Event

Event poster

ESC Congress 2019

3 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Eicosapentaenoic acid therapy is associated with decreased coronary plaque instability assessed using optical frequency domain imaging
3 September 2019
thumbnail
Congress Presentation
Endothelial dysfunction in the post-COVID-19 period: a meta-analysis
29 August 2022
thumbnail
Congress Presentation
Changes in TRG/ApoA-1 ratio, TRG/HDL-C ratio and lipid serum profile after combination therapy with valsartan/amlodipine in prediabetic patients
7 April 2022
thumbnail
Congress Presentation
EPA:DHA 6:1 prevents right ventricular dysfunction and lung vascular remodeling in monocrotaline-induced pulmonary arterial hypertension in rats by mitigating inflammatory and pro-oxidant responses
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources